Ticagrelor versus clopidogrel for prevention of subclinical stent thrombosis detected by optical coherence tomography in patients with drug-eluting stent implantation—a multicenter and randomized study-Reference-Cited by-同舟云学术

Ticagrelor versus clopidogrel for prevention of subclinical stent thrombosis detected by optical coherence tomography in patients with drug-eluting stent implantation—a multicenter and randomized study

Published:2020-04-24 Issue:3 Volume:32 Page:404-412
ISSN:0953-7104
Container-title:Platelets
language:en
Short-container-title:Platelets

Author:

Wu Xiangqi¹,You Wei¹,Wu Zhiming¹,Wu Qiang²,Jiang Jun³,Yan Hua⁴,Ye Fei¹,Chen Shaoliang¹

Affiliation:

1. Division of Cardiology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China

2. Division of Cardiology, Xuzhou Central Hospital, Xuzhou, China

3. Division of Cardiology, The Second Affiliated Hospital of Zhejiang University, Hangzhou, China

4. Division of Cardiology, Wuhan Asian Heart Hospital, Wuhan, China

Funder

National Natural Scientific Foundation of China

the AstraZeneca Corp of China

Publisher

Informa UK Limited

Subject

Hematology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/09537104.2020.1754381

Reference33 articles.

1. Comparisons of Baseline Demographics, Clinical Presentation, and Long-Term Outcome Among Patients With Early, Late, and Very Late Stent Thrombosis of Sirolimus-Eluting Stents

2. Long-Term Clinical Outcome After a First Angiographically Confirmed Coronary Stent Thrombosis

3. Incidence and Morphological Predictors of Intrastent Coronary Thrombus After Drug-Eluting Stent Implantation (from a Multicenter Registry)

4. Stent Thrombosis in Randomized Clinical Trials of Drug-Eluting Stents

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dynamic natural components and morphological changes in nonculprit subclinical atherosclerosis in patients with acute coronary syndrome and mild chronic kidney disease at the 1-year follow-up and clinical significance at the 5-year follow-up;PLOS ONE;2024-05-31

2. Comparison between ticagrelor and clopidogrel in patients with acute coronary syndrome undergoing percutaneous coronary intervention: A systematic review and meta-analysis;Journal of Medicine, Surgery, and Public Health;2024-04

3. Comparison of Clopidogrel and Ticagrelor for Dual Antiplatelet Therapy of Patients with Unruptured Cerebral Aneurysms Undergoing Endovascular Treatment;World Neurosurgery;2023-09

4. The efficacy and safety of the prasugrel, ticagrelor, and clopidogrel dual antiplatelet therapies following an acute coronary syndrome: A systematic review and Bayesian network meta-analysis;2023-08-16

5. Morphologies and composition changes in nonculprit subclinical atherosclerosis in diabetic versus nondiabetic patients with acute coronary syndrome who underwent long-term statin therapy;Scientific Reports;2023-04-01